familial histiocytic reticulosis; familial hemophagocytic reticulosis; familial hemophagocytic lymphohistiocytosis; familial erythrophagocytic lymphohistiocytosis
Jump to navigation
Jump to search
Epidemiology
rare
Pathology
- immune dysregulation
- hypercytokinemia
- defective natural killer cell function
- excessive T-cell activation & macrophage activation
- hemophagocytosis is a prominent feature
- infiltrates of macrophages & activated T lymphocytes in lymph nodes, in liver, spleen, bone marrow, nervous system (non-malignant)
Genetics
- multiple genes involved in different forms
Clinical manifestations
- lethal disorder of early childhood
- fever
- hepatosplenomegaly
- neurological abnormalities ranging from irritability & hypotonia to seizures, cranial nerve deficits, & ataxia
Laboratory
- complete blood count (CBC): cytopenia
- lipid panel: hypertriglyceridemia
- hypofibrinogenemia
- low plasma fibrinogen
- low ESR
Management
- epipodophyllotoxins
- immunosuppression
- bone marrow transplant
- without treatment, disease progresses rapidly
More general terms
- hemophagocytic lymphohistiocytosis; hemophagocytic syndrome
- genetic disease of the immune system
- genetic disease of the blood/bone marrow
More specific terms
- familial hemophagocytic lymphohistiocytosis type 1 (HPLH1)
- familial hemophagocytic lymphohistiocytosis type 2 (HPLH2)
- familial hemophagocytic lymphohistiocytosis type 3 (HPLH3)
- familial hemophagocytic lymphohistiocytosis type 4 (HPLH4)
- Omenn syndrome; familial reticuloendotheliosis with eosinophilia
Patient information
familial hemophagocytic lymphohistiocytosis patient information